A recent study demonstrates that sustained GPX4 blockade via sophisticated lipidic nanoplatforms simultaneously triggers robust ferroptosis and remodels the tumor immune microenvironment; however, the underlying synergistic mechanisms remain poorly elucidated. Here, GPX4 is linked to neoplasm.